NYSE:CBT - Cabot Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$42.80 -1.08 (-2.46 %)
(As of 05/19/2019 04:00 PM ET)
Previous Close$42.80
Today's Range$42.7350 - $43.82
52-Week Range$39.57 - $67.80
Volume213,844 shs
Average Volume375,987 shs
Market Capitalization$2.50 billion
P/E Ratio10.62
Dividend Yield3.08%
Beta1.4
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. Further, it provides cesium formate brines used as a drilling and completion fluid primarily in high pressure and high temperature oil and gas well construction; and fine cesium chemicals used in a range of industries and applications that include catalysts, doping agents, and brazing fluxes. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

Receive CBT News and Ratings via Email

Sign-up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
CUSIP12705510
Phone617-345-0100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.24 billion
Cash Flow$8.0150 per share
Book Value$21.07 per share

Profitability

Net Income$-113,000,000.00

Miscellaneous

Employees4,600
Market Cap$2.50 billion
Next Earnings Date8/5/2019 (Estimated)
OptionableOptionable

Cabot (NYSE:CBT) Frequently Asked Questions

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot declared a quarterly dividend on Thursday, May 9th. Investors of record on Friday, May 31st will be paid a dividend of $0.35 per share on Friday, June 14th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 3.27%. The ex-dividend date is Thursday, May 30th. This is a boost from Cabot's previous quarterly dividend of $0.33. View Cabot's Dividend History.

How will Cabot's stock buyback program work?

Cabot declared that its board has authorized a stock repurchase plan on Monday, July 16th 2018, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 10.3% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

How were Cabot's earnings last quarter?

Cabot Corp (NYSE:CBT) posted its quarterly earnings data on Monday, May, 6th. The specialty chemicals company reported $0.99 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.97 by $0.02. The specialty chemicals company had revenue of $844 million for the quarter, compared to analyst estimates of $868 million. Cabot had a net margin of 8.13% and a return on equity of 19.06%. The company's quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.04 earnings per share. View Cabot's Earnings History.

When is Cabot's next earnings date?

Cabot is scheduled to release their next quarterly earnings announcement on Monday, August 5th 2019. View Earnings Estimates for Cabot.

What guidance has Cabot issued on next quarter's earnings?

Cabot updated its FY19 earnings guidance on Monday, May, 6th. The company provided earnings per share guidance of $4.05-4.30 for the period, compared to the Thomson Reuters consensus estimate of $4.38. Cabot also updated its FY 2019 guidance to $4.05-4.30 EPS.

What price target have analysts set for CBT?

3 brokers have issued 12-month target prices for Cabot's stock. Their predictions range from $75.00 to $82.00. On average, they anticipate Cabot's stock price to reach $77.6667 in the next year. This suggests a possible upside of 81.5% from the stock's current price. View Analyst Price Targets for Cabot.

What is the consensus analysts' recommendation for Cabot?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cabot.

Has Cabot been receiving favorable news coverage?

Media stories about CBT stock have been trending somewhat positive this week, InfoTrie reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cabot earned a news sentiment score of 1.9 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are some of Cabot's key competitors?

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Energy Transfer LP Unit (ET), JPMorgan Chase & Co. (JPM), Broadcom (AVGO), CHURCHILL CAP C/SH (CCC), AT&T (T), Wells Fargo & Co (WFC), Oracle (ORCL), Adobe (ADBE), CVS Health (CVS) and Ford Motor (F).

Who are Cabot's key executives?

Cabot's management team includes the folowing people:
  • Mr. Sean D. Keohane, Pres, CEO & Director (Age 52)
  • Ms. Erica McLaughlin, Sr. VP & CFO (Age 43)
  • Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 57)
  • Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 49)
  • Mr. Patrick M. Prevost, Advisor & Director (Age 64)

Who are Cabot's major shareholders?

Cabot's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.69%), Wellington Management Group LLP (5.13%), LSV Asset Management (4.65%), Dimensional Fund Advisors LP (2.42%), FMR LLC (2.01%) and Victory Capital Management Inc. (1.92%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.

Which major investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Cabot Wellington LLC, Fiduciary Trust Co., Natixis, Kennedy Capital Management Inc., BlackRock Inc., JPMorgan Chase & Co. and BNP Paribas Arbitrage SA. Company insiders that have sold Cabot company stock in the last year include Brian A Berube, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Insider Buying and Selling for Cabot.

Which major investors are buying Cabot stock?

CBT stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Deprince Race & Zollo Inc., Ceredex Value Advisors LLC, Royce & Associates LP, Dimensional Fund Advisors LP, Hotchkis & Wiley Capital Management LLC, Hotchkis & Wiley Capital Management LLC and Hillcrest Asset Management LLC. View Insider Buying and Selling for Cabot.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $42.80.

How big of a company is Cabot?

Cabot has a market capitalization of $2.50 billion and generates $3.24 billion in revenue each year. The specialty chemicals company earns $-113,000,000.00 in net income (profit) each year or $4.03 on an earnings per share basis. Cabot employs 4,600 workers across the globe.

What is Cabot's official website?

The official website for Cabot is http://www.cabot-corp.com.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]


MarketBeat Community Rating for Cabot (NYSE CBT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  317 (Vote Outperform)
Underperform Votes:  373 (Vote Underperform)
Total Votes:  690
MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel